Advertisement
Advertisement
U.S. markets open in 7 hours 35 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Eagle Pharmaceuticals, Inc. (EGRX)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
51.55-0.74 (-1.42%)
At close: 4:00PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close52.29
Open52.20
Bid51.03 x 800
Ask0.00 x 1000
Day's Range51.47 - 52.58
52 Week Range36.48 - 58.25
Volume61,592
Avg. Volume100,490
Market Cap675.156M
Beta (5Y Monthly)0.78
PE Ratio (TTM)38.24
EPS (TTM)1.35
Earnings DateNov 01, 2021 - Nov 05, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est48.50
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
-23% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for EGRX

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Eagle Pharmaceuticals, Inc.
    EGRX: Rating increased to a BUYEAGLE PHARMACEUTICALS INC has an Investment Rating of BUY; a target price of $59.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
    Rating
    Fair Value
    Economic Moat
    13 days agoArgus Research
View more
Advertisement
Advertisement